Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA masitinib CTRPv2 pan-cancer AAC 0.043 0.3
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.04 0.3
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA B02 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA lovastatin CTRPv2 pan-cancer AAC -0.043 0.3
mRNA importazole CTRPv2 pan-cancer AAC -0.044 0.3
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.082 0.3
mRNA ELCPK CTRPv2 pan-cancer AAC 0.057 0.3
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.044 0.3
Download CSV